Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Kristof Van Emelen, Sint-Niklaas BE

Kristof Van Emelen, Sint-Niklaas BE

Patent application numberDescriptionPublished
20080255140Squaric Acid Derivatives as Inhibitors of Histone Deacetylase - This invention comprises the novel compounds of formula (I)10-16-2008
20090042920CARBONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE - This invention comprises the novel compounds of formula (I)02-12-2009
20100009988PIPERAZINYL-, PIPERIDINYL- AND MORPHOLINYL-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE - This invention comprises the novel compounds of formula (I)01-14-2010
20100010004INHIBITORS OF HISTONE DEACETYLASE - This invention comprises the novel compounds of formula (I)01-14-2010
20100048588AMINOCARBONYL-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE - This invention comprises the novel compounds of formula (I)02-25-2010
201000694243-CYANO-QUINOLINE DERIVATIVES WITH ANTIPROLIFERATIVE ACTIVITY - The present invention concerns the compounds of formula03-18-2010
20100160321IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE - This invention comprises the novel compounds of Formula (I) wherein R06-24-2010
20100173913PYRIDO-AND PYRIMIDOPYRIMIDINE DERIVATIVES AS ANTI-PROLIFERATIVE AGENTS - The present invention concerns the compounds of formula07-08-2010
20100190786INDOLIN-2-ONES AND AZA-INDOLIN-2-ONES - The present invention relates to compounds or pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy. The invention particularly relates to certain indolin-2-ones and aza-indolin-2-ones which possess anti-tumour activity and are accordingly useful in methods of treatment of the human or animal body, in particular such compounds are useful in the treatment of pathological processes which involve an aberrant cellular proliferation, such as tumor growth, rheumatoid arthritis, restenosis and atherosclerosis.07-29-2010
20100204197PYRROLOPYRIMIDINES - The present invention relates to compounds or pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy. The invention particularly relates to compounds that are polo-like kinase (PLKs) inhibitors useful for the treatment of disease states mediated by PLK, especially PLK4, in particular such compounds that are useful in the treatment of pathological processes which involve an aberrant cellular proliferation, such as tumour growth, rheumatoid arthritis, restenosis and atherosclerosis.08-12-2010
20100222574CYCLIC ANILINO - PYRIDINOTRIAZINES - The present invention concerns the compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein m represents 1, n represents 1, Z represents N or C, in particular N; —X09-02-2010
20100234353SULFONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE - This invention comprises the novel compounds of formula (I)09-16-2010
201100094044-ARYL-2-ANILINO-PYRIMIDINES - The present invention relates to compounds of Formula (Ia) or (Ib), the N-oxide forms, pharmaceutically acceptable addition salts, quaternary amines, stereoisomers, tautomers, racemics, metabolites, prodrugs, hydrates, or solvates thereof,01-13-2011
20110136841SUBSTITUTED INDOLYL ALKYL AMINO DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE - This invention comprises the novel compounds of formula (I)06-09-2011

Patent applications by Kristof Van Emelen, Sint-Niklaas BE